A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)

Clinical trial NCT06886659 · COMPLETED

Trial details

NCT number: NCT06886659
Sponsor: Incepta Pharmaceuticals Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Breast Neoplasms Breast Disease Antineoplastic Agents

Start date: 2024-01-23
Primary completion: 2024-12-28
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.